The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Constipation-Global Market Insights and Sales Trends 2024
Synopsis
Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing is termed as constipation. Constipation may be occasional which lasts for few weeks or may be chronic which lasts for longer period and is recurrent. It may be associated with other conditions such as irritable bowel syndrome or opioid consumption.
The global Constipation market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Constipation in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Constipation market. Chronic Idiopathic Constipation (CIC), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Irritable Bowel Syndrome With Constipation (IBS-C) segment is estimated at % CAGR for the next seven-year period.
Based on disease type, the global constipation treatment market is segmented into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C) and opioid induced constipation (OIC). High prevalence of chronic constipation is estimated to contribute for dominating share of CIC segment in global market while increasing opioid consumption is projected to propel for exponential growth of OIC segment during forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Constipation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Constipation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Constipation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Constipation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Constipation covered in this report include Takeda Pharmaceutical, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Bausch Health, Abbott, AstraZeneca, Cosmo Pharmaceuticals and Sanofi, etc.
The global Constipation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda Pharmaceutical
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Bausch Health
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong Pharmaceuticals
Bayer
Prestige Brands Holdings
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion
Global Constipation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Constipation market, Segment by Type:
Chronic Idiopathic Constipation (CIC)
Irritable Bowel Syndrome With Constipation (IBS-C)
Opioid-Induced Constipation (OIC)
Global Constipation market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Constipation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing is termed as constipation. Constipation may be occasional which lasts for few weeks or may be chronic which lasts for longer period and is recurrent. It may be associated with other conditions such as irritable bowel syndrome or opioid consumption.
The global Constipation market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Constipation in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Constipation market. Chronic Idiopathic Constipation (CIC), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Irritable Bowel Syndrome With Constipation (IBS-C) segment is estimated at % CAGR for the next seven-year period.
Based on disease type, the global constipation treatment market is segmented into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C) and opioid induced constipation (OIC). High prevalence of chronic constipation is estimated to contribute for dominating share of CIC segment in global market while increasing opioid consumption is projected to propel for exponential growth of OIC segment during forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Constipation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Constipation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Constipation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Constipation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Constipation covered in this report include Takeda Pharmaceutical, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Bausch Health, Abbott, AstraZeneca, Cosmo Pharmaceuticals and Sanofi, etc.
The global Constipation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda Pharmaceutical
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Bausch Health
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong Pharmaceuticals
Bayer
Prestige Brands Holdings
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion
Global Constipation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Constipation market, Segment by Type:
Chronic Idiopathic Constipation (CIC)
Irritable Bowel Syndrome With Constipation (IBS-C)
Opioid-Induced Constipation (OIC)
Global Constipation market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Constipation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Constipation
1.1 Constipation Market Overview
1.1.1 Constipation Product Scope
1.1.2 Constipation Market Status and Outlook
1.2 Global Constipation Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Constipation Market Size by Region (2018-2029)
1.4 Global Constipation Historic Market Size by Region (2018-2023)
1.5 Global Constipation Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Constipation Market Size (2018-2029)
1.6.1 North America Constipation Market Size (2018-2029)
1.6.2 Europe Constipation Market Size (2018-2029)
1.6.3 Asia-Pacific Constipation Market Size (2018-2029)
1.6.4 Latin America Constipation Market Size (2018-2029)
1.6.5 Middle East & Africa Constipation Market Size (2018-2029)
2 Constipation Market by Type
2.1 Introduction
2.1.1 Chronic Idiopathic Constipation (CIC)
2.1.2 Irritable Bowel Syndrome With Constipation (IBS-C)
2.1.3 Opioid-Induced Constipation (OIC)
2.2 Global Constipation Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Constipation Historic Market Size by Type (2018-2023)
2.2.2 Global Constipation Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Constipation Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Constipation Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Constipation Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Constipation Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Constipation Revenue Breakdown by Type (2018-2029)
3 Constipation Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Constipation Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Constipation Historic Market Size by Application (2018-2023)
3.2.2 Global Constipation Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Constipation Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Constipation Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Constipation Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Constipation Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Constipation Revenue Breakdown by Application (2018-2029)
4 Constipation Competition Analysis by Players
4.1 Global Constipation Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Constipation as of 2022)
4.3 Date of Key Players Enter into Constipation Market
4.4 Global Top Players Constipation Headquarters and Area Served
4.5 Key Players Constipation Product Solution and Service
4.6 Competitive Status
4.6.1 Constipation Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Takeda Pharmaceutical
5.1.1 Takeda Pharmaceutical Profile
5.1.2 Takeda Pharmaceutical Main Business
5.1.3 Takeda Pharmaceutical Constipation Products, Services and Solutions
5.1.4 Takeda Pharmaceutical Constipation Revenue (US$ Million) & (2018-2023)
5.1.5 Takeda Pharmaceutical Recent Developments
5.2 Synergy Pharmaceuticals
5.2.1 Synergy Pharmaceuticals Profile
5.2.2 Synergy Pharmaceuticals Main Business
5.2.3 Synergy Pharmaceuticals Constipation Products, Services and Solutions
5.2.4 Synergy Pharmaceuticals Constipation Revenue (US$ Million) & (2018-2023)
5.2.5 Synergy Pharmaceuticals Recent Developments
5.3 Sucampo Pharmaceuticals
5.3.1 Sucampo Pharmaceuticals Profile
5.3.2 Sucampo Pharmaceuticals Main Business
5.3.3 Sucampo Pharmaceuticals Constipation Products, Services and Solutions
5.3.4 Sucampo Pharmaceuticals Constipation Revenue (US$ Million) & (2018-2023)
5.3.5 Ironwood Pharmaceuticals Recent Developments
5.4 Ironwood Pharmaceuticals
5.4.1 Ironwood Pharmaceuticals Profile
5.4.2 Ironwood Pharmaceuticals Main Business
5.4.3 Ironwood Pharmaceuticals Constipation Products, Services and Solutions
5.4.4 Ironwood Pharmaceuticals Constipation Revenue (US$ Million) & (2018-2023)
5.4.5 Ironwood Pharmaceuticals Recent Developments
5.5 Bausch Health
5.5.1 Bausch Health Profile
5.5.2 Bausch Health Main Business
5.5.3 Bausch Health Constipation Products, Services and Solutions
5.5.4 Bausch Health Constipation Revenue (US$ Million) & (2018-2023)
5.5.5 Bausch Health Recent Developments
5.6 Abbott
5.6.1 Abbott Profile
5.6.2 Abbott Main Business
5.6.3 Abbott Constipation Products, Services and Solutions
5.6.4 Abbott Constipation Revenue (US$ Million) & (2018-2023)
5.6.5 Abbott Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca Constipation Products, Services and Solutions
5.7.4 AstraZeneca Constipation Revenue (US$ Million) & (2018-2023)
5.7.5 AstraZeneca Recent Developments
5.8 Cosmo Pharmaceuticals
5.8.1 Cosmo Pharmaceuticals Profile
5.8.2 Cosmo Pharmaceuticals Main Business
5.8.3 Cosmo Pharmaceuticals Constipation Products, Services and Solutions
5.8.4 Cosmo Pharmaceuticals Constipation Revenue (US$ Million) & (2018-2023)
5.8.5 Cosmo Pharmaceuticals Recent Developments
5.9 Sanofi
5.9.1 Sanofi Profile
5.9.2 Sanofi Main Business
5.9.3 Sanofi Constipation Products, Services and Solutions
5.9.4 Sanofi Constipation Revenue (US$ Million) & (2018-2023)
5.9.5 Sanofi Recent Developments
5.10 Daewoong Pharmaceuticals
5.10.1 Daewoong Pharmaceuticals Profile
5.10.2 Daewoong Pharmaceuticals Main Business
5.10.3 Daewoong Pharmaceuticals Constipation Products, Services and Solutions
5.10.4 Daewoong Pharmaceuticals Constipation Revenue (US$ Million) & (2018-2023)
5.10.5 Daewoong Pharmaceuticals Recent Developments
5.11 Bayer
5.11.1 Bayer Profile
5.11.2 Bayer Main Business
5.11.3 Bayer Constipation Products, Services and Solutions
5.11.4 Bayer Constipation Revenue (US$ Million) & (2018-2023)
5.11.5 Bayer Recent Developments
5.12 Prestige Brands Holdings
5.12.1 Prestige Brands Holdings Profile
5.12.2 Prestige Brands Holdings Main Business
5.12.3 Prestige Brands Holdings Constipation Products, Services and Solutions
5.12.4 Prestige Brands Holdings Constipation Revenue (US$ Million) & (2018-2023)
5.12.5 Prestige Brands Holdings Recent Developments
5.13 Janssen Pharmaceutical
5.13.1 Janssen Pharmaceutical Profile
5.13.2 Janssen Pharmaceutical Main Business
5.13.3 Janssen Pharmaceutical Constipation Products, Services and Solutions
5.13.4 Janssen Pharmaceutical Constipation Revenue (US$ Million) & (2018-2023)
5.13.5 Janssen Pharmaceutical Recent Developments
5.14 Shionogi
5.14.1 Shionogi Profile
5.14.2 Shionogi Main Business
5.14.3 Shionogi Constipation Products, Services and Solutions
5.14.4 Shionogi Constipation Revenue (US$ Million) & (2018-2023)
5.14.5 Shionogi Recent Developments
5.15 Albireo Pharma
5.15.1 Albireo Pharma Profile
5.15.2 Albireo Pharma Main Business
5.15.3 Albireo Pharma Constipation Products, Services and Solutions
5.15.4 Albireo Pharma Constipation Revenue (US$ Million) & (2018-2023)
5.15.5 Albireo Pharma Recent Developments
5.16 Renexxion
5.16.1 Renexxion Profile
5.16.2 Renexxion Main Business
5.16.3 Renexxion Constipation Products, Services and Solutions
5.16.4 Renexxion Constipation Revenue (US$ Million) & (2018-2023)
5.16.5 Renexxion Recent Developments
6 North America
6.1 North America Constipation Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Constipation Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Constipation Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Constipation Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Constipation Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Constipation Market Dynamics
11.1 Constipation Industry Trends
11.2 Constipation Market Drivers
11.3 Constipation Market Challenges
11.4 Constipation Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
